Flávio Kapczinski mainly investigates Bipolar disorder, Internal medicine, Psychiatry, Clinical psychology and Mania. His Bipolar disorder study incorporates themes from Brain-derived neurotrophic factor, Mood disorders and Mood. His work deals with themes such as Major depressive disorder, Endocrinology and Schizophrenia, which intersect with Internal medicine.
His study in the field of Psychological intervention, Anxiety disorder and Psychosocial is also linked to topics like Suicide attempt. His Clinical psychology research includes themes of Neurocognitive, Cognition, Allostatic load, Neuroimaging and Comorbidity. His Mania research integrates issues from Psychopharmacology and Placebo-controlled study.
The scientist’s investigation covers issues in Bipolar disorder, Psychiatry, Internal medicine, Clinical psychology and Endocrinology. His Bipolar disorder research incorporates themes from Cognition, Mood disorders and Mood. Psychiatry is a component of his Depression, Anxiety, Comorbidity, Major depressive disorder and Schizophrenia studies.
His research links Oncology with Internal medicine. His Clinical psychology study integrates concerns from other disciplines, such as Neurocognitive and Prevalence of mental disorders. His Brain-derived neurotrophic factor research is classified as research in Neurotrophic factors.
His primary areas of study are Bipolar disorder, Psychiatry, Clinical psychology, Cognition and Mood. His Bipolar disorder research is multidisciplinary, incorporating perspectives in Major depressive disorder, Internal medicine and Pediatrics. His Internal medicine research focuses on subjects like Endocrinology, which are linked to Schizophrenia.
His study on Anxiety and Bipolar I disorder is often connected to Suicide attempt and Suicide prevention as part of broader study in Psychiatry. Flávio Kapczinski focuses mostly in the field of Clinical psychology, narrowing it down to matters related to Neurocognitive and, in some cases, Functional impairment and Quality of life. His study looks at the relationship between Mood and fields such as Mood disorders, as well as how they intersect with chemical problems.
His primary areas of investigation include Bipolar disorder, Clinical psychology, Psychiatry, Cognition and Depression. His primary area of study in Bipolar disorder is in the field of Mania. He has included themes like Precision medicine, Cognitive impairment, MEDLINE, Visual memory and Working memory in his Clinical psychology study.
His study in Psychiatry is interdisciplinary in nature, drawing from both Stage and Family history. His research integrates issues of Psychopathology and Lifestyle factors in his study of Cognition. His Depression study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors
Michael Berk;Flavio P Kapczinski;Ana Cristina Andreazza;Ana Cristina Andreazza;Olivia Dean;Olivia Dean.
Neuroscience & Biobehavioral Reviews (2011)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
Lakshmi N Yatham;Sidney H Kennedy;Ayal Schaffer;Sagar V Parikh.
Bipolar Disorders (2009)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Lakshmi N Yatham;Sidney H Kennedy;Sagar V Parikh;Ayal Schaffer.
Bipolar Disorders (2018)
The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen.
American Journal of Psychiatry (2013)
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
Mateus M. Bergamaschi;Regina Helena Costa Queiroz;Regina Helena Costa Queiroz;Marcos Hortes Nisihara Chagas;Marcos Hortes Nisihara Chagas;Danielle Chaves Gomes De Oliveira;Danielle Chaves Gomes De Oliveira.
Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder.
Adriane Ribeiro Rosa;Jose Sanchez-Moreno;Anabel Martínez-Aran;Manel Salamero.
Clinical Practice & Epidemiology in Mental Health (2007)
Oxidative stress markers in bipolar disorder: a meta-analysis
Ana C. Andreazza;Marcia Kauer-Sant'Anna;Benicio N. Frey;David J. Bond.
Journal of Affective Disorders (2008)
Allostatic load in bipolar disorder: implications for pathophysiology and treatment.
Flavio Kapczinski;Eduard Vieta;Eduard Vieta;Ana Cristina Andreazza;Benicio N. Frey.
Neuroscience & Biobehavioral Reviews (2008)
Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.
Angelo B.M. Cunha;Benicio N. Frey;Ana C. Andreazza;Júlia D. Goi.
Neuroscience Letters (2006)
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.
Márcia Kauer-Sant'Anna;Márcia Kauer-Sant'Anna;Flávio Pereira Kapczinski;Ana Cristina Andreazza;Ana Cristina Andreazza;David J. Bond.
The International Journal of Neuropsychopharmacology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: